Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ambison Pharmaceutical is a pharmaceutical company focused on the development, manufacturing, and commercialization of high-quality therapeutic products, with a particular emphasis on gastroenterology and digestive health. The company is best known for its production of proton pump inhibitors (PPIs) and other gastrointestinal medications designed to treat acid-related disorders such as peptic ulcers and GERD. Ambison operates modern manufacturing facilities that adhere to Good Manufacturing Practice (GMP) standards to ensure product safety and efficacy. By leveraging its expertise in formulation and chemical synthesis, the company aims to provide affordable and effective treatment options for patients globally.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ambison Pharmaceutical.